Long cycle-life wound lithium-ion battery cells having metallized film current collectors
US-2024358635-A1 · Oct 31, 2024 · US
US9526716B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9526716-B2 |
| Application number | US-201514935036-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 6, 2015 |
| Priority date | Sep 16, 2011 |
| Publication date | Dec 27, 2016 |
| Grant date | Dec 27, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to combinations of an agent that stimulates cell proliferation and an anti-inflammatory/analgesic, which are useful in the treatment of peripheral ulcers of various origins, such as radiation dermatitis, diabetic ulcers, ulcers caused by venous stasis of the limbs, bedsores, and the associated skin infections, proctitis, vulvovaginitis and haemorrhoids with vascular lesions. These combinations can be presented as formulations for topical use.
Opening claim text (preview).
The invention claimed is: 1. A method of treating peripheral ulcers, radiodermitis induced by radiotherapy and chemotherapy, ulcerated haemorrhoids, proctitis and vulvovaginitis in a subject in need thereof, said method comprising: administering an effective amount of a composition comprising: a) bisulphite adducts of anthocyanosides from Vaccinium myrtillus, b) a lipophilic extract of Echinacea sp., to a subject in need thereof; and treating said subject. 2. The method according to claim 1 , wherein the ulcers are diabetic ulcers, ulcers of the limbs due to venous stasis, ulcers due to radiation or mechanical or thermal injuries and bedsores. 3. The method according to claim 1 , wherein the composition further comprises anthocyanosides from Vaccinium myrtillus. 4. The method according to claim 3 , wherein the ulcers are diabetic ulcers, ulcers of the limbs due to venous stasis, ulcers due to radiation or mechanical or thermal injuries and bedsores.
Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers · CPC title
for hyperglycaemia, e.g. antidiabetics · CPC title
Local antiseptics · CPC title
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.